Literature DB >> 17060448

"Skittish" Abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system.

Jody T Mack1, Vladimir Beljanski, Athena M Soulika, Danyelle M Townsend, Carol B Brown, Warren Davis, Kenneth D Tew.   

Abstract

The ATP-binding cassette transporter 2 (ABCA2) is an endolysosomal protein most highly expressed in the central and peripheral nervous system tissues and macrophages. Previous studies indicated its role in cholesterol/steroid (estramustine, estradiol, and progesterone) trafficking/sequestration, oxidative stress response, and Alzheimer's disease. Developmental studies have shown its expression during macrophage and oligodendrocyte differentiation, processes requiring membrane growth. To determine the in vivo function(s) of this transporter, we generated a knockout mouse from a gene-targeted disruption of the murine ABCA2 gene. Knockout males and females are viable and fertile. However, a non-Mendelian inheritance pattern was shown among male progeny of heterozygous crosses. Compared to wild-type and heterozygous littermates, knockout mice displayed a tremor without ataxia, hyperactivity, and reduced body weight; the latter two phenotypes were more marked in females than in males. This sexual disparity suggests a role for ABCA2 in hormone-dependent neurological and/or developmental pathways. Myelin sheath thickness in the spinal cords of knockout mice was greatly increased compared to that in wild-type mice, while a significant reduction in myelin membrane periodicity (compaction) was observed in both spinal cords and cerebra of knockout mice. Loss of ABCA2 function in vivo resulted in abnormal myelin compaction in spinal cord and cerebrum, an ultrastructural defect that we propose to be the cause of the phenotypic tremor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060448      PMCID: PMC1800669          DOI: 10.1128/MCB.01824-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.

Authors:  Simon N Fewou; Heinrich Büssow; Nicole Schaeren-Wiemers; Marie T Vanier; Wendy B Macklin; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

Review 2.  Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.

Authors:  M J Rowan; I Klyubin; Q Wang; R Anwyl
Journal:  Biochem Soc Trans       Date:  2005-08       Impact factor: 5.407

3.  High cholesterol level is essential for myelin membrane growth.

Authors:  Gesine Saher; Britta Brügger; Corinna Lappe-Siefke; Wiebke Möbius; Ryu-ichi Tozawa; Michael C Wehr; Felix Wieland; Shun Ishibashi; Klaus-Armin Nave
Journal:  Nat Neurosci       Date:  2005-03-27       Impact factor: 24.884

4.  Expression of ABCA2 protein in human vestibular schwannoma and peripheral nerve.

Authors:  Yan Wang; Katsuya Yamada; Yukiko Tanaka; Kazuo Ishikawa; Nobuya Inagaki
Journal:  J Neurol Sci       Date:  2005-05-15       Impact factor: 3.181

5.  Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.

Authors:  N M Laing; M G Belinsky; G D Kruh; D W Bell; J T Boyd; L Barone; J R Testa; K D Tew
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.

Authors:  Sandrine Macé; Emmanuelle Cousin; Sylvain Ricard; Emmanuelle Génin; Emmanuel Spanakis; Carole Lafargue-Soubigou; Bérengère Génin; Raphaël Fournel; Sandrine Roche; Gilles Haussy; Florence Massey; Stéphane Soubigou; Georges Bréfort; Patrick Benoit; Alexis Brice; Dominique Campion; Melvyn Hollis; Laurent Pradier; Jésus Benavides; Jean-François Deleuze
Journal:  Neurobiol Dis       Date:  2005-02       Impact factor: 5.996

Review 7.  Cholesterol and prostate cancer.

Authors:  Michael R Freeman; Keith R Solomon
Journal:  J Cell Biochem       Date:  2004-01-01       Impact factor: 4.429

8.  ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities.

Authors:  Michael L Fitzgerald; Kei-Ichiro Okuhira; Glenn F Short; Jennifer J Manning; Susan A Bell; Mason W Freeman
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

9.  Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein.

Authors:  C Xie; S D Turley; P G Pentchev; J M Dietschy
Journal:  Am J Physiol       Date:  1999-02

10.  MUTANT MICE (QUAKING AND JIMPY) WITH DEFICIENT MYELINATION IN THE CENTRAL NERVOUS SYSTEM.

Authors:  R L SIDMAN; M M DICKIE; S H APPEL
Journal:  Science       Date:  1964-04-17       Impact factor: 47.728

View more
  21 in total

1.  ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migration.

Authors:  Jody T Mack; Kristi L Helke; Gabrielle Normand; CoDanielle Green; Danyelle M Townsend; Kenneth D Tew
Journal:  Cancer Lett       Date:  2010-10-30       Impact factor: 8.679

2.  The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2013-11-05

3.  The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene.

Authors:  Warren Davis
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

4.  Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.

Authors:  Brenda Huang; WenJie Wei; Guohao Wang; Marta A Gaertig; Yue Feng; Wei Wang; Xiao-Jiang Li; Shihua Li
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

Review 5.  ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.

Authors:  Warren Davis; Kenneth D Tew
Journal:  Biochem Pharmacol       Date:  2017-12-06       Impact factor: 5.858

6.  Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies.

Authors:  Jody T Mack; Carol B Brown; Tracy E Garrett; Joachim D Uys; Danyelle M Townsend; Kenneth D Tew
Journal:  Biomed Pharmacother       Date:  2012-07-02       Impact factor: 6.529

7.  Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-β production by altering Nicastrin maturation and intracellular localization.

Authors:  Vasiliki Michaki; Francesc X Guix; Krist'l Vennekens; Sebastian Munck; Colin Dingwall; John B Davis; Danyelle M Townsend; Kenneth D Tew; Fabian Feiguin; Bart De Strooper; Carlos G Dotti; Tina Wahle
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

8.  Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress.

Authors:  Danyelle M Townsend; Yefim Manevich; Lin He; Steven Hutchens; Christopher J Pazoles; Kenneth D Tew
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

9.  Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis.

Authors:  Lan N Tu; Kanako Morohaku; Pulak R Manna; Susanne H Pelton; W Ronald Butler; Douglas M Stocco; Vimal Selvaraj
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

10.  Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture.

Authors:  Lei-Miao Yin; Gong-Hao Jiang; Yu Wang; Yan Wang; Yan-Yan Liu; Wei-Rong Jin; Yu-Dong Xu; Qing-Hua Zhang; Yong-Qing Yang
Journal:  J Biomed Sci       Date:  2009-05-06       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.